BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37842898)

  • 1. An Overview of Diabetic Cardiomyopathy.
    Quaiyoom A; Kumar R
    Curr Diabetes Rev; 2024; 20(5):e121023222139. PubMed ID: 37842898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic cardiomyopathy--fact or fiction?
    Maisch B; Alter P; Pankuweit S
    Herz; 2011 Mar; 36(2):102-15. PubMed ID: 21424347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparate Clinical Characteristics and Prognosis of HFpEF versus HFrEF Phenotype of Diabetic Cardiomyopathy.
    Li Z; Shi Y; Xia Y; Wu L; Li H; Zhou R; Gao X; Zhang H; Jin X; Zhang J
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants.
    Prandi FR; Evangelista I; Sergi D; Palazzuoli A; Romeo F
    Heart Fail Rev; 2023 May; 28(3):597-606. PubMed ID: 35001338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Cardiac Fibrosis in Diabetic Cardiomyopathy: From Pathophysiology to Clinical Diagnostic Tools.
    Pan KL; Hsu YC; Chang ST; Chung CM; Lin CL
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.
    Tarquini R; Pala L; Brancati S; Vannini G; De Cosmo S; Mazzoccoli G; Rotella CM
    Curr Med Chem; 2018; 25(13):1510-1524. PubMed ID: 28685679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
    Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
    Xu L; Zhang Y; Kuang Y; Fang H; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):689-696. PubMed ID: 34382584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic heart disease: A clinical update.
    Rajbhandari J; Fernandez CJ; Agarwal M; Yeap BXY; Pappachan JM
    World J Diabetes; 2021 Apr; 12(4):383-406. PubMed ID: 33889286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.
    Hahn VS; Knutsdottir H; Luo X; Bedi K; Margulies KB; Haldar SM; Stolina M; Yin J; Khakoo AY; Vaishnav J; Bader JS; Kass DA; Sharma K
    Circulation; 2021 Jan; 143(2):120-134. PubMed ID: 33118835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].
    Pankuweit S; Richter A; Ruppert V; Maisch B
    Herz; 2009 Feb; 34(1):55-62. PubMed ID: 19214409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
    Gollmer J; Zirlik A; Bugger H
    J Lipid Atheroscler; 2019 May; 8(1):26-47. PubMed ID: 32821697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension.
    Son TK; Toan NH; Thang N; Le Trong Tuong H; Tien HA; Thuy NH; Van Minh H; Valensi P
    Cardiovasc Diabetol; 2022 May; 21(1):75. PubMed ID: 35568879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diabetic cardiomyopathy.
    Tarquini R; Lazzeri C; Pala L; Rotella CM; Gensini GF
    Acta Diabetol; 2011 Sep; 48(3):173-81. PubMed ID: 20198391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.